By Caden DeLisa | The Capitolist

Earlier this month, Gov. Ron DeSantis laid out his plan to work with state lawmakers during the upcoming Legislative Session to pass a series of laws to “increase transparency” in the pharmaceutical industry.

According to the governor, the pieces of legislation will impose a range of regulations and guidelines including, but not limited to, consumer and small business protections and requirements that drug manufacturers must disclose proposed price increases before they take effect.

Further, the proposal seeks to enact anti-steering measures, preventing the implementation of a pharmaceutical network that only includes PBM-affiliated pharmacies.

“These reforms will enhance transparency and reduce the influence of pharmacy middlemen, which will help consumers as well as our small pharmacies,” said DeSantis. “I look forward to these reforms becoming law.”

Read More